论文部分内容阅读
Atezolizumab(atezo)as first-line(1L)therapy in cisplatin-ineligible locally advanced/metastatic urot
【作 者】
:
【机 构】
:
Perlmutter Cancer Center,NYU Langone Medical Center,New York,NY
【出 处】
:
2016年临床肿瘤学新进展学术研讨会
【发表日期】
:
2016年5期
其他文献
FAST:An international,multicenter,randomized,phase Ⅱ trial of epirubicin,oxaliplatin,and capecitabin
会议
NETTER-1 phase Ⅲ:Efficacy and safety results in patients with midgut neuroendocrine tumors treated w
会议
Phase Ⅲ randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced he
会议
A multicenter randomized phase Ⅲ trial of neo-adjuvant chemotherapy followed by surgery and chemothe
会议
Cabazitaxel vs docetaxel in chemotherapy-naive(CN)patients with metastatic castrationresistant prost
会议
ESPAC-4:A multicenter,international,open-label randomized controlled phase Ⅲ trial ofadjuvant combin
会议
A randomized phase Ⅲ trial between adjuvant docetaxel and surveillance after radical prostatectomy f
会议
Quality of life(QOL)analysis from CHAARTED:Chemohormonal androgen ablation randomized trial in prost
会议